Edwards B E, Couch N W, Myers K D, Blanchard S G, Chandra G, Parr A F
Glaxo Wellcome Inc., Research Triangle Park, NC 27709, USA.
Health Phys. 1996 Sep;71(3):379-83. doi: 10.1097/00004032-199609000-00017.
A wide variety of radioactive waste is generated by pharmaceutical research. One particularly high volume low specific activity waste stream produced by a research and development facility is aqueous 125I waste. This waste is generally held for decay and released to the sanitary sewer when the activity is low enough to ensure that concentrations are well below the appropriate regulatory limits. However, the large volume of this particular waste stream rapidly exhausted available space to store it for decay. This study investigated safe, inexpensive, and efficient methods for removing 125I from the aqueous waste, with the goal of implementing a practical process for concentrating the activity and thus reducing the stored volume. The implemented treatment (volume reduction) process used commercially available low cost activated carbon/particulate filters and inexpensive resin beds manufactured in-house. The much smaller volumes of spent filters and resin beds are then held for decay and eventual incineration. This technique has proven an effective means for managing this high volume waste stream.
药物研究产生了各种各样的放射性废物。一家研发机构产生的一种特别大量的低比活度废物流是含125I的水性废物。这种废物通常存放至衰变,当活度低到足以确保浓度远低于适当的监管限值时,再排放到生活污水管道。然而,这种特定废物流的大量产生迅速耗尽了用于储存衰变的可用空间。本研究调查了从水性废物中去除125I的安全、廉价且高效的方法,目标是实施一种实用的浓缩活度从而减少储存体积的工艺。所实施的处理(体积减少)工艺使用了市售低成本活性炭/颗粒过滤器以及内部制造的廉价树脂床。然后将体积小得多的用过的过滤器和树脂床存放至衰变并最终焚烧。该技术已证明是管理这种大量废物流的有效手段。